Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.
Method Article
* Wspomniani autorzy wnieśli do projektu równy wkład.
The leptomeninges explant culture protocol from human postmortem brain is a technically robust and simple way to derive fibronectin-positive meningeal fibroblasts within 6-8 weeks and cryopreserve approximately 20-30 million cells.
Even though great progress has been made in the clinical characterization of Parkinson's disease, several studies report that the diagnosis of Parkinson's disease is not pathologically confirmed in up to 25% of clinically diagnosed Parkinson's disease. Therefore, tissue collected from clinically diagnosed patients with idiopathic Parkinson's disease can have a high rate of misdiagnosis; hence in vitro studies from such tissues to study Parkinson's disease as a preclinical model can become futile.
By collecting postmortem human leptomeninges with a confirmed neuropathological diagnosis of Parkinson's disease and characterized by nigrostriatal cell loss and intracellular protein inclusions called Lewy bodies, one can be certain that clinically observed parkinsonism is not caused by another underlying disease process (e.g. tumor, arteriosclerosis).
This protocol presents the dissection and preparation of postmortem human leptomeninges for derivation of a meningeal fibroblast culture. This procedure is robust and has a high success rate. The challenge of the culture is sterility as the brain procurement is generally not performed under sterile conditions. Therefore, it is important to supplement the culture media with a cocktail of penicillin, streptomycin, and amphotericin B.
The derivation of meningeal fibroblasts from autopsy-confirmed cases with Parkinson's disease provides the foundation for in vitro modeling of Parkinson's disease. Meningeal fibroblasts appear 3-9 days after sample preparation and about 20-30 million cells can be cryopreserved in 6-8 weeks. The meningeal fibroblast culture is homogenous and the cells express fibronectin, a commonly used marker to identify meninges.
Meninges consist of three membranes that protect the brain: dura mater, arachnoid and pia mater. More recently, it has been recognized that meninges also play an important role in brain development and brain homeostasis1. Meninges are derived from mesenchymal and neural crest-derived cells and interestingly, it has been shown that progenitor cells residing in meninges can give rise to neurons in vitro and after transplantation in vivo2,3,4. Meninges cultures have been also successfully used as feeder layers, as they possess stromal cell-derived inducing activity for differentiation of embryonic stem cells into dopaminergic neurons5. Moreover, leptomeninges have the potential to directly differentiate into neurons, astrocytes, and oligodendrocytes under ischemic conditions6.
For this protocol, human postmortem meninges samples are collected from the arachnoid and pia mater, collectively called the leptomeninges, and are procured as part of a human brain donation for research purposes. Dissection of the brain is performed within 24 h of death and the leptomeninges sample is placed in cold growth media for further processing within the next 6-8 h as illustrated here in this protocol.
This protocol describes the dissection and preparation of human meninges samples for the development of patient primary leptomeninges cell culture. The tissue is cut into 25-30 pieces of approximately 3 mm x 3 mm squares. Three pieces are placed in each 6-well gelatin-coated well and held down with round glass coverslips. The meninges dissection takes about 25-35 min. The main challenge with this culture is sterility as the brain procurement, transport, and dissection are generally not performed under sterile conditions. Therefore, it is important to supplement the culture media with a cocktail of penicillin, streptomycin, and amphotericin B and use multi-well dishes to separately culture tissue pieces.
Outgrowth of meningeal fibroblasts occurs usually within the first week. Media is changed every two to three days until cells are confluent and the cells are enzymatically passaged. The meningeal fibroblasts are cryopreserved at 1 million cells per mL/vial in cryopreservation media. With this protocol, 20-30 million meningeal fibroblasts can be derived in 6-8 weeks for cryopreservation. Downstream applications of these meningeal fibroblasts are primary cultures for disease research, direct neuronal differentiation or derivation of induced pluripotent stem cells from the leptomeninges for understanding of disease mechanisms and for drug development.
The brain donation registration includes documentation by the registrant of their intent to donate. The autopsy permission for tissue retrieval is provided by the next of kin as permitted by law. Research studies using collected autopsy specimens are reviewed by the institutional review board (IRB) to ensure compliance with Health Insurance Portability and Accountability Act (HIPAA) regulations.
NOTE: Leptomeninges samples are collected by the brain dissector or neuropathologist during a brain dissection and are stored in 50 mL conical tubes containing 25-30 mL meninges growth media. The sample is stored at 4 °C until sample preparation. The processing should be performed as soon as possible as the viability of cells decreases with time post mortem.
1. Set-up before Starting the Leptomeninges Dissection
NOTE: Steps 1.1 - 1.3 are to be performed inside a biosafety cabinet.
2. Preparation of Leptomeninges Sample
NOTE: Steps 2.1 - 2.3 are to be performed inside a biosafety cabinet.
3. Dissection of Leptomeninges Tissue
NOTE: Steps 3.1 - 3.3 are to be performed inside a horizontal laminar flow hood using a dissecting microscope.
4. Transfer of Dissected Meninges Pieces onto Tissue Culture Plates
NOTE: Step 4 is to be performed inside a biosafety cabinet.
5. Placement of Cover Slips over Meninges Pieces
NOTE: Steps 5.1 - 5.2 are to be performed inside a horizontal laminar flow hood using a dissecting microscope.
6. Cell Culture Maintenance
NOTE: Steps 6.1 - 6.3 are to be performed inside a biosafety cabinet. Handle culture dishes with care as coverslips should not move and dislodge the meninges pieces.
7. Passaging
NOTE: All steps are to be performed inside a biosafety cabinet. Once meningeal fibroblasts have migrated out of the meningeal tissue pieces and start to grow towards the edges of the culture vessel, expand meningeal fibroblasts into larger culture dish.
8. Characterization of the Meningeal Fibroblasts by Immunostaining
NOTE: Before starting the procedure, prepare 4% paraformaldehyde solution, 5% normal goat serum in PBS (blocking buffer), 0.3% Triton X-100 in PBS (permeabilization buffer), primary and secondary antibody solutions, and 1 µg/mL of Hoechst 33342 diluted in PBS from 10 mg/mL stock.
When the leptomeninges processing protocol has been successful, outgrowth of meningeal fibroblasts is first observed three to nine days after dissection, although this can depend on the length of post-mortem interval for the brain. Figure 1 demonstrates meningeal fibroblast cultures of four different donors. Figure 1A shows a leptomeninges piece held down by a glass cover slip (dark diagonal line) and fibroblast outgrowth around the tissue four days after...
This protocol describes a simple and robust protocol to derive a meningeal fibroblast culture from human postmortem leptomeninges collected in conjunction with a brain donation. There are very few descriptions of protocols to derive cell cultures from postmortem human material. Two studies describe skin-derived fibroblast cultures7,8,9, one study describes dura samples10, and another describes non-cryopre...
The authors have nothing to disclose.
Development of this protocol was funded by private donations directed to the Parkinson's Institute Brain Donation Program.
Name | Company | Catalog Number | Comments |
Corning Petri dishes | Fisher Scientific | 351029 | |
Nunc 6-well plate | Fisher Scientific | 14-832-11 | |
15-mm cover slips | Fisher Scientific | 12-545-83 15CIR-1D | |
Scalpels, sterile blade, No. 15 | Miltex | 4-415 | |
Curved precision tip forceps | Fisher Scientific | 16-100-122 | |
Serological pipettes | Fisher Scientific | 13-678-11E | |
Pasteur pipettes | Fisher Scientific | 22-230490 | |
Gelatin | Sigma | G1890-100G | |
Phosphate Buffer Saline | Fisher Scientific | SH30264.02 | |
Corning 500 mL filter unit | Fisher Scientific | 430770 | Combine media components and filter. |
Nunc Cell Culture Treated Flasks with Filter Caps, T175 cm2 | Thermo Scientific | 178883 | |
Name | Company | Catalog Number | Comments |
Growth Media | |||
Hyclone DMEM | Fisher Scientific | SH30081.02 | |
Hyclone FBS | Fisher Scientific | SH30910.03 | |
MEM Non-Essential Amino Acids Solution (100x) | Thermo Fisher | 11140-050 | |
GlutaMAX Supplement (100x) | Thermo Fisher | 35050-061 | |
Sodium Pyruvate (100 mM) | Thermo Fisher | 11360-070 | |
Penicillin-Streptomycin (10,000 U/mL) | Thermo Fisher | 15140-122 | |
Amphotericin B (Yellow Solution/250 µg/mL) | Fisher Scientific | BP264520 | |
Bambanker Freeze 120 mL | Fisher Scientific | NC9582225 | |
Name | Company | Catalog Number | Comments |
Fibronectin Staining | |||
8 well chamber slides | Fisher Scientific | 1256518 | |
20% paraformaldehyde | Electron Microscopy Sciences | 15713 | |
Triton X-100 | Sigma | T8787 | |
100% Glycerol | BioRad | 9455 | |
100% normal goat serum | Fisher Scientific | 101098-382 | |
Anti-Fibronectin antibody [F1] | Abcam | ab32419 | 1:300 dilution in blocking solution |
Anti-SERPINH1 | Sigma | S5950-200ul | 1:250 dilution in blocking solution |
Anti-SOX2 | Millipore | MAB4343 | 1:100 dilution in blocking solution |
Anti-Nestin | Millipore | MAB5326 | 1:200 dilution in blocking solution |
Anti-TUJ1 | Covance | MMS-435P | 1:1,000 dilution in blocking solution |
Alexa Fluor 488 anti-rabbit | Thermo Fisher | A11029 | 1:400 dilution in blocking solution; (green channel; Ex/Em2 495/519 nm) |
Alexa Fluor 555 anti-mouse | Thermo Fisher | A21424 | 1:400 dilution in blocking solution; (red channel; Ex/Em2 590/617 nm) |
Hoechst 33342 stain | Thermo Fisher | H3570 | dilute to a final concentration of 1.0 μg/mL; (blue channel; Ex/Em2 358/461 nm) |
Suppliers are suggestions, similar products from alternative vendors can be used as well. |
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone